Clinical Trials Logo

Clinical Trial Summary

Muscle relaxants represent an important part of general anesthesia in adult and pediatric patients. Their role is to facilitate intubation and enable some surgical interventions. At our workplace, monitoring of the depth of neuromuscular blockade is a standard procedure in accordance with the 2017 recommendation of ČSARIM entitled "Principles of Patient Safety in Anesthesiology" [1,2]. At present, we mainly use rocuronium. One of the advantages of this non-depolarizing steroidal muscle relaxant with a rapid onset and intermediate duration of action is the existence of the specific antagonist sugammadex.


Clinical Trial Description

Given the observational study design, we expect that no informed consent will be required. In pediatric patients undergoing a planned general anesthesia with non-depolarizing muscle relaxants, induction of anesthesia will involve either standard intravenous (an opioid, anesthetic, muscle relaxant) or inhalational agents according to the preference of the anesthesiologist. Standard monitoring during general anesthesia will be carried out including measurement of the depth of neuromuscular blockade (Train of Four, TOF, Avance CS2 machine, relaxometry module, stimulating current of 50 mA) every minute and body temperature monitoring. Subsequently, these parameters including the age-related minimum alveolar concentration of sevoflurane will be documented in the Case Report Form (CRF). Rocuronium will be administered at a dose according to the Summary of Product Characteristics (SPC) and local expertise. Patient demographic parameters, dose of rocuronium, time of its administration, and time of TOF 1 measurement (= clinical effect, stimulation of the ulnar nerve - adductor pollicis muscle tension) will be documented in the CRF and if there is no need to add further doses of the muscle relaxant, TOF 2, TOF 3, TOF 4, and TOF-R ≥ 0,9 (= time to full recovery from the effect of the non-depolarizing muscle relaxant) will also be registered. In addition, reversal of neuromuscular blockade if applicable and the Aldrete score in the first and fifth minute after extubation will be recorded. In patients monitored after an intervention in a recovery room, possible complications occurring within at least 30 minutes postoperatively will be documented (desaturation, the need for oxygen therapy, tachycardia >150 beats per minute, bradycardia <50 beats per minute, aspiration, sore throat, cough, hoarseness). All patients will be screened for aspiration pneumonia on chest X-ray within the first 24 hours after an intervention. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05529420
Study type Observational
Source Brno University Hospital
Contact Katarina Szturzova, MD
Phone 532234695
Email Szturzova.Katarina@fnbrno.cz
Status Recruiting
Phase
Start date September 5, 2022
Completion date September 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT01228162 - Influence of Muscle Relaxation With Rocuronium Bromide During General Anaesthesia on Muscle Trauma and Postoperative Analgetic Consumption in Patients With Total Hip Prosthesis Implantation Phase 4
Recruiting NCT03801785 - Efficacy of Non-Nutritive Sucking (NNS) on Balance and Gait Measured in 12-42 Month-Old Healthy Children Over 36 Months N/A
Completed NCT02778932 - Comparison of Intubation and Laryngeal Mask for Pars Plana Vitrectomy
Recruiting NCT01389791 - MgSO4 Combined With Rocuronium Priming N/A
Not yet recruiting NCT06394245 - Progressive Relaxation Exercises for Kidney Donors N/A
Completed NCT04012762 - Vibration Training and Muscles Properties N/A
Recruiting NCT03060707 - Continuous Infusion Versus Intermittent Bolus Injection of Rocuronium Phase 4
Active, not recruiting NCT02669368 - Magnesium Sulfate Effects on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy Phase 2
Completed NCT01906528 - Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium Phase 1
Not yet recruiting NCT05736744 - Effect of Magnesium Sulphate Pretreatment in Pediatric Laparoscopy Phase 2/Phase 3
Completed NCT03926650 - The Correlation Between the Frontal Electromyography Parameter in Patient State Index (PSI) Monitor and Train of Four
Completed NCT03112564 - Endotracheal Intubation Without Muscle Relaxants N/A
Completed NCT05432570 - Use of Muscle Relaxants in Parotidectomy Operation With Neuromonitoring N/A
Completed NCT00984633 - Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED) Phase 3
Completed NCT03573895 - Stretching vs Foam-rolling N/A
Completed NCT03381209 - The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium. N/A
Recruiting NCT05911867 - Muscle Energy Technique and Mulligan's Mobilization in Breast Cancer Surgery Patients N/A
Recruiting NCT05757999 - Effect of MgSO4 Pretreatment on Muscle Relaxation Phase 2/Phase 3
Completed NCT02185339 - Effects of Deep Neuromuscular Blockade on Intraoperative Respiratory Mechanics Phase 4
Completed NCT02498678 - Effect of Tetanus on Neuromuscular Junction Monitor Performance in Pediatric Patients N/A